GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
|
IN |
|
Huabang Technology Holdings Ltd
HKEX:3638
|
HK |
|
Voyager Digital Ltd
TSX:VOYG
|
US |
|
A
|
Ashnoor Textile Mills Ltd
BSE:507872
|
IN |
|
KIOCL Ltd
NSE:KIOCL
|
IN |
|
Kingboard Laminates Holdings Ltd
HKEX:1888
|
HK |
|
F
|
Fullink Technology Co Ltd
SZSE:301067
|
CN |
|
T
|
Toray Industries Inc
OTC:TRYIY
|
JP |
|
Fermenta Biotech Ltd
BSE:506414
|
IN |
Bankruptcy Probability
GlaxoSmithKline Pharmaceuticals Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
GlaxoSmithKline Pharmaceuticals Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
|
397.5B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
GlaxoSmithKline Pharmaceuticals Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, GlaxoSmithKline Pharmaceuticals Ltd has total debt of 219.6m INR. This includes both short-term (0 INR) and long-term (219.6m INR) debt.
You can find a full breakdown on its Balance Sheet.
